Dr. Aaron Light named Provost at Ozarks Tech
SPRINGFIELD, Mo. — Ozarks Tech has revealed their new Provost and Executive Vice Chancellor for Academic Affairs.
Dr. Aaron Light was chosen after serving the college as the Dean of Health Sciences since 2021.
'Throughout his time as Dean of Health Sciences, Dr. Light has played a pivotal role in shaping the future of our academic programs,' Hal Higdon, Ozarks Tech Chancellor, said in a press release. 'His visionary leadership propelled transformative growth in student enrollment, expanded our programmatic offerings and forged meaningful partnerships with leaders in healthcare and local industry.'
Former Bolivar schools teacher pleads not guilty to child endangerment
Light is known for being instrumental in developing Missouri's first bachelor's degree offered by a community college. He has also been known for being a faculty member for the Respiratory Therapy Program, Director of Clinical Education for 12 years and then Program Director for six years.
'I'm honored to step into the role of provost at the college that has been my home for over two decades,' Light says in a press release. 'From my days as a student to serving as faculty, program director and dean, I've witnessed firsthand the incredible journey of growth – from classrooms in malls to six thriving campuses and centers. It's a privilege to help shape the next chapter of this remarkable institution.'
Light will be appointed to his new role on July 1, appending approved by OTC Board of Trustees.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
5 days ago
- Yahoo
BenQ Launches Flagship ScreenBar® Halo 2 to Redefine Eye Comfort for Professionals Working in the Dark
PLANO, Texas, June 3, 2025 /CNW/ -- BenQ, the pioneer of monitor lighting solutions, today launched the ScreenBar® Halo 2, its next-generation flagship monitor light engineered to deliver optimal eye comfort for professionals working in dim environments. Developed over four years, the ScreenBar® Halo 2 enhances workspace lighting through a powerful dual-light design that provides full front and rear illumination. Building on the success of its predecessor, the ScreenBar® Halo 2 introduces a Tri-zone Backlight Design that expands coverage by 423%, reducing contrast between the monitor and its surroundings to ease visual fatigue. The front light features BenQ's ASYM-Light™, an asymmetrical optical design with an 18-degree cut-off angle that eliminates screen glare and prevents direct light from reaching the eyes. The product's development was informed by a study conducted in collaboration with National Taiwan University of Science and Technology, which found that maintaining balanced ambient light around a screen significantly improves eye comfort. Backed by ANSI standards, the optimal luminance ratio of no more than 3:1 between the screen and its surroundings is a core element of the ScreenBar® Halo 2's design. "We know professionals demand precision in lighting," said JC Pan, Chief Product Designer at BenQ Smart Lighting. "That's why we've revamped the control knob, making it easy to adjust brightness (0–100%) and color temperature (2700K–6500K) on an anti-fingerprint coated panel—ideal for tasks like color grading or video editing." The mounting system also received a complete redesign. Inspired by the gravity-based mechanism of the ScreenBar Pro, the new zinc-alloy clamp supports a wide variety of monitors, from ultra-thin to curved, without causing damage. "It rests gently on the screen instead of clipping on, making it far more screen-friendly," said Judy Yang, lead mechanical engineer. The ScreenBar® Halo 2 comes packed with smart features, including auto-dimming, auto on/off, and memory settings for personalized use. Co-designed with MINIMAL Design, founded by former Nike Global Creative Director Scott Wilson, it features a sleek metallic finish that complements any professional setup. To celebrate the launch, BenQ is giving away 50 free units of the ScreenBar® Halo 2 across different regions. To enter, users simply need to complete a short questionnaire about their workspace habits. The giveaway is part of the #ElevatewithHalo campaign, where professionals will share how the product enhances their workflow and comfort. #ElevatewithHalo runs from June 3 to June 20, more: To learn more about BenQ monitor lighting series, please visit: Since introducing the world's first monitor light bar in 2017, BenQ Smart Lighting has led innovation in professional lighting. With a mission to improve eye comfort and productivity, BenQ delivers intelligent, user-centric solutions for modern workspaces. Media Contact:Jensen SM ChimProduct Manager, BenQ Smart LightingEmail: View original content to download multimedia: SOURCE BenQ View original content to download multimedia:
Yahoo
6 days ago
- Yahoo
Blue Mountain Launches Spring 2025 RAM Release, Advancing Asset Management for Life Sciences
Release enables smarter maintenance, seamless mobile workflows and the introduction of artificial intelligence for improved documentation search STATE COLLEGE, Pa., June 02, 2025 (GLOBE NEWSWIRE) -- Blue Mountain, the leader in GMP-compliant Enterprise Asset Management (EAM) software for life sciences, announces the launch of its Spring 2025 RAM Release, introducing advanced capabilities that drive operational excellence, maximize compliance, and empower mobile teams across the Life Sciences industry. The Spring 2025 release builds on RAM's trusted foundation by delivering enhancements in three transformative areas: Condition-Based Maintenance (CBM): Enables organizations to move beyond scheduled routines to smarter, condition-driven workflows. Real-time threshold management and automatic task generation ensure precision interventions, reducing downtime and cutting maintenance costs. RAM Mobile Enhancements: Teams can now execute work plans offline, submit mobile requests with photos, and maintain data integrity on the go. These updates dramatically reduce mean time to detection and improve documentation completeness. Artificial Intelligence: Now available in validation environments, RAMMY AI delivers instant, contextual answers sourced directly from validated documentation—slashing lookup times by up to 98% and unlocking daily productivity gains. 'Our Spring 2025 Release represents a major step toward predictive maintenance and mobile-first efficiency,' said Judy Fainor, Chief Technology Officer. 'With condition-based maintenance, powerful mobile capabilities, and the introduction of AI, we're enabling Life Sciences teams to work smarter, faster, and more compliantly than ever.' About Blue Mountain Blue Mountain is the leader in enterprise asset management for Life Sciences. For over 35 years, Blue Mountain has been committed to delivering innovative and high-quality solutions that ensure regulatory compliance, enable operational efficiency and equipment uptime, and provide insights that optimize asset lifecycle management. Trusted by more than 450+ Life Sciences companies, the Blue Mountain industry-leading cloud platform helps companies master end-to-end GMP asset management from set-up to installation and from training to validation. Blue Mountain is backed by Accel-KKR and headquartered in State College, PA. For more information, please visit and follow the company on LinkedIn. Media Contact: Christian Rockwellcarockwell@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Insider
6 days ago
- Business Insider
Gilead announces data on Trodelvy plus Keytruda
Gilead (GILD) Sciences announced Trodelvy plus Keytruda reduced the risk of disease progression or death by 35% versus standard of care Keytruda plus chemotherapy in first-line treatment for patients with PD-L1+ metastatic triple-negative breast cancer, TNBC. Trodelvy when given in combination with Keytruda resulted in a median progression-free survival of 11.2 months vs 7.8 months when Keytruda was given in combination with chemotherapy. These data from the pivotal Phase 3 ASCENT-04/KEYNOTE-D19 study will be presented today as a late-breaking oral presentation at the 2025 ASCO Annual Congress. For the primary endpoint, the median PFS was 11.2 months with Trodelvy plus Keytruda compared to 7.8 months with Keytruda plus chemotherapy, with a median follow-up of 14 months. A highly statistically significant and clinically meaningful improvement was observed with Trodelvy plus Keytruda, showing a 35% reduction in the risk of disease progression or death in the intent to treat population compared to standard of care Keytruda plus chemotherapy combination. The PFS benefit was generally consistent across key prespecified subgroups. A numerically higher overall response rate was observed for the Trodelvy plus Keytruda combination including 13% and 8% with a complete response, respectively, in the Trodelvy plus Keytruda and Keytruda plus chemotherapy arms. Notably, a substantially longer duration of response was observed with Trodelvy plus Keytruda.
